Correlation Between Kura Oncology and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Kura Oncology and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Syndax Pharmaceuticals.
Diversification Opportunities for Kura Oncology and Syndax Pharmaceuticals
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kura and Syndax is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Kura Oncology i.e., Kura Oncology and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kura Oncology and Syndax Pharmaceuticals
Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Syndax Pharmaceuticals. In addition to that, Kura Oncology is 1.35 times more volatile than Syndax Pharmaceuticals. It trades about -0.21 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 1,921 in Syndax Pharmaceuticals on August 27, 2024 and sell it today you would lose (248.00) from holding Syndax Pharmaceuticals or give up 12.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kura Oncology vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Kura Oncology |
| Syndax Pharmaceuticals |
Kura Oncology and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kura Oncology and Syndax Pharmaceuticals
The main advantage of trading using opposite Kura Oncology and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
| Syndax Pharmaceuticals vs. Eliem Therapeutics | Syndax Pharmaceuticals vs. HCW Biologics | Syndax Pharmaceuticals vs. Scpharmaceuticals | Syndax Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |